These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 959398)

  • 1. New methods in the cultivation of Valeriana officinalis.
    Czabajska W; Jaruzelski M; Ubysz D
    Planta Med; 1976 Aug; 30(1):9-13. PubMed ID: 959398
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dependence of the valepotriate and essential oil content in Valeriana officinalis L.s.l. on various exogenous and endogenous factors].
    Wagner H; Schaette R; Hörhammer L; Hölzl J
    Arzneimittelforschung; 1972 Jul; 22(7):1204-9. PubMed ID: 4678131
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemical weed control in the cropping of medicinal plants. Part 1: Valerian (Valeriana officinalis L.) (author's transl)].
    Pank F; Hannig HJ; Hauschild J; Zygmunt B
    Pharmazie; 1980 Feb; 35(2):115-9. PubMed ID: 7384179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution to the study of valerian alcaloids (Valeriana officinalis, L.): actinidine and naphthyridylmethylketone, a new alkaloid (author's transl)].
    Janot MM; Guilhem J; Contz O; Venera G; Cionga E
    Ann Pharm Fr; 1979; 37(9-10):413-20. PubMed ID: 547813
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tests of "industrial lyophilization" of medicinal plants. 3. Valeriana officinalis L. Influence of lyophilization on the quality of the drug].
    Paris R; Besson P; Hérisset A
    Ann Pharm Fr; 1966 Nov; 24(11):669-74. PubMed ID: 5987652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evolution of the concentration of valtrates in Valeriana procurrens Wallr. cultivated in conditioned media].
    Mélotte R
    J Pharm Belg; 1973; 28(3):373-83. PubMed ID: 4733874
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interspecific and intraspecific comparison of valepotrates contents in three Valeriana plants].
    Chen L; Qin L; Zheng H; Nian H; Guo C; Zhang C
    Zhong Yao Cai; 2002 Apr; 25(4):237-8. PubMed ID: 12583171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative ethnomedical study of Valeriana officinalis L].
    Tucakov J
    Glas Srp Akad Nauka Med; 1965; (18):131-50. PubMed ID: 5879763
    [No Abstract]   [Full Text] [Related]  

  • 9. [Callus cultures of a Valerian species. 1. Installation of a callus culture of Valeriana Wallichii DC and 1st analytical studies].
    Becker H; Schrall R; Hartmann W
    Arch Pharm (Weinheim); 1977 Jun; 310(6):481-4. PubMed ID: 883877
    [No Abstract]   [Full Text] [Related]  

  • 10. A disturbance of microsporogenesis in experimental polyploids of Valeriana nitida.
    Shugaeva EV
    Sov Genet; 1974 Jul; 8(7):830-7. PubMed ID: 4424323
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of chemical races, sources, cultivars and species for the in vivo preparation of radioactive labelled natural compounds, described von Valeriana (author's transl)].
    Hölzl J
    Planta Med; 1975 Nov; 28(3):300-14. PubMed ID: 1197435
    [No Abstract]   [Full Text] [Related]  

  • 12. [Active substances in Valeriana officinalis L].
    Bucková A; Grznár K; Haladová M; Eisenreichová E
    Cesk Farm; 1977 Sep; 26(7):308-9. PubMed ID: 603922
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on HPLC fingerprint of the hydrophilic constituents of Valeriana medicinal plants].
    Shi JL; Liu Y; Xiao PG
    Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(6):426-9. PubMed ID: 15810445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Valeroside A--a glycoside from valerian (Valeriana officinalis L.)].
    Nikul'shina NI; Talan VA; Bukharov VG; Ivanova VM
    Farmatsiia; 1969; 18(6):44-7. PubMed ID: 5379672
    [No Abstract]   [Full Text] [Related]  

  • 15. Valepotriate content in different in vitro cultures of Valerianaceae and characterization of Valeriana officinalis L. callus during a growth period.
    Violon C; Van Cauwenbergh N; Vercruysse A
    Pharm Weekbl Sci; 1983 Oct; 5(5):205-9. PubMed ID: 6646985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Toxicological Risk Assessment of Lead and Cadmium in Valeriana officinalis L., radix (Valerian root) as Herbal Medicinal Product for the Relief of Mild Nervous Tension and Sleep Disorders Available in Polish Pharmacies.
    Jurowski K; Fołta M; Tatar B; Berkoz M; Krośniak M
    Biol Trace Elem Res; 2022 Feb; 200(2):904-909. PubMed ID: 33792859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seasonal changes of valeropotriates in native Valeriana procurrens Wallr].
    Chapelle JP
    J Pharm Belg; 1972; 27(5):570-6. PubMed ID: 4660645
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biosynthesis of alkaloids, valtrates and volatile oils in the roots of Valeriana officinalis L. from radioactive precursors].
    Verzárné Petri G
    Acta Pharm Hung; 1974 Jun; 0(0):suppl 1:54-65. PubMed ID: 4845468
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of Valeriana officinalis L extract on cardiovascular system].
    Zhang BH; Meng HP; Wang T; Dai YC; Shen J; Tao C; Wen SR; Qi Z; Ma L; Yuan SH
    Yao Xue Xue Bao; 1982 May; 17(5):382-4. PubMed ID: 7180472
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the cultivation of Kesso (Kamebakisso, Valeriana sp.) and Hokkaikisso (V. sp.). I].
    Hatakeyama Y; Homma N; Hemmi S; Hikino H
    Eisei Shikenjo Hokoku; 1971; 89():67-72. PubMed ID: 5170097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.